【ChiCTR-IIR-17011735】Single shot versus continuous saphenous nerve block for postoperative pain management after total knee replacement: a randomised, double-blind trial
ChiCTR-IIR-17011735
尚未开始
/
/
/
2017-06-22
/
/
Primary osteoarthritis of knee undergoing total knee replacement
Single shot versus continuous saphenous nerve block for postoperative pain management after total knee replacement: a randomised, double-blind trial
Single shot versus continuous saphenous nerve block for postoperative pain management after total knee replacement: a randomised, double-blind trial
852
To investigate and compare the effect of single shot versus continuous saphenous nerve blockade on pain control in the early postoperative period for patients undergoing unilateral primary total knee replacement.
随机平行对照
Ⅳ期
Randomization will be performed by computer program and the results will be sealed in concealed envelops.
/
Departmental funding
/
30
/
2017-10-01
2018-06-30
/
1. Primary, unilateral total knee replacement under central neuroaxial block; 2. Aged 18 to 80 years; 3. American Society of Anesthesiologists (ASA) physical status I – III.；
请登录查看1. Patients with secondary osteoarthritis of the knee; 2. Patients undergoing operation under general anaesthesia; 3. Pregnancy; 4. Body weight < 45 kg or body mass index > 40 kg/m2; 5. Allergy to opioid or local anaesthetics; 6. Patients with contraindications to COX-2 inhibitors use; 7. Chronic opioid use (> 1 month of 60mg morphine oral equivalents daily); 8. Subject refusal.；
请登录查看Department of Anaesthesia and Intensive Care, Pok Oi Hospital
852
Department of Anaesthesia and Intensive Care, Pok Oi Hospital的其他临床试验
Department of Anaesthesia and Intensive Care, Pok Oi Hospital的其他临床试验
最新临床资讯
-
大鹏制药临床III期成功
新药说2026-08-13
-
新一代 EGFR-TKI 首个全球 III 期成功
丁香园 Insight 数据库2026-08-13
-
体外诊断原料网2026-08-13
-
佰傲谷BioValley2026-08-13
-
久有基金2026-08-13
-
重庆宸安生物2026-08-13
-
UmabsDB2026-08-13
-
希格生科2026-08-13
-
bioSeedin柏思荟2026-08-13
-
智飞智讯2026-08-13
全球药物研发中心
全球研发数据与行业前沿情报
研发动态
相关报告
政策法规
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 20 8
-
摩熵咨询 34 27
-
摩熵咨询 20 5
-
颁布机构：四川省经济和信息化厅、中共四川省委军民融合发展委员会办公室、四川省教育厅、四川省科学技术厅、四川省人力资源和社会保障厅、四川省卫生健康委员会、四川省医疗保障局、四川省中医药管理局、四川省药品监督管理局 2026-08-04
-
颁布机构：国家医保局 2026-07-31
-
颁布机构：国家药品审评中心（CDE） 2026-07-24
医药市场洞察中心
医药市场销售数据分析 · 智能洞察 · 竞争格局监测
-
医药市场销售数据分析 · 医院、实体药店、网上药店
-
市场竞争格局分析(靶点、药品类型、ATC大类)
市场动态
市场报告
政策法规
-
2026-08-13
-
2026-08-13
-
2026-08-13
-
摩熵咨询 35 36
-
摩熵咨询 28 39
-
摩熵咨询 34 18
-
颁布机构：国家市场监督管理总局 2026-08-10
-
颁布机构：国家市场监督管理总局 2026-05-29
-
颁布机构：国家市场监督管理总局 2026-05-29